385 related articles for article (PubMed ID: 19265305)
21. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
[TBL] [Abstract][Full Text] [Related]
22. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
Hertzberg MS; Favaloro E; Koutts J
Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
[No Abstract] [Full Text] [Related]
23. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
24. Acquired hemophilia: a case report.
Flisiński M; Windyga J; Stefańska E; Huszcza S; Donderski R; Manitius J
Pol Arch Med Wewn; 2008 Apr; 118(4):228-33. PubMed ID: 18575423
[TBL] [Abstract][Full Text] [Related]
25. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
[TBL] [Abstract][Full Text] [Related]
26. [Transient inhibitors developed in two cases of hemophilia A].
Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S
Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
[TBL] [Abstract][Full Text] [Related]
27. Acquired hemophilia A caused by factor VIII inhibitors: report of a case.
Hosoya Y; Matsumura M; Madoiwa S; Zuiki T; Matsumoto S; Nunomiya S; Lefor A; Sata N; Yasuda Y
Surg Today; 2013 Jun; 43(6):670-4. PubMed ID: 22890583
[TBL] [Abstract][Full Text] [Related]
28. [Acquired hemophilia A after an early abortion].
Wullen B; Mühlhöfer A; Luz H; Zoller WG
Dtsch Med Wochenschr; 2002 May; 127(20):1075-8. PubMed ID: 12016555
[TBL] [Abstract][Full Text] [Related]
29. Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions.
Ng HJ; Tan DC; Lee LH
Haemophilia; 2006 Jul; 12(4):423-8. PubMed ID: 16834745
[TBL] [Abstract][Full Text] [Related]
30. [Severe bleeding in a case of factor VIII inhibitor associated with intravascular lymphomatosis].
Ohtaka A; Muroi K; Izumi T; Suzuki T; Hoshino M; Miwa A; Sakata Y; Sakamoto S; Miura Y; Shinohara N
Rinsho Ketsueki; 1993 Feb; 34(2):194-9. PubMed ID: 8492418
[TBL] [Abstract][Full Text] [Related]
31. Successful steroid pulse treatment in childhood acquired haemophilia with nephrotic syndrome.
Sakai M; Shima M; Shirahata A
Haemophilia; 2005 May; 11(3):285-9. PubMed ID: 15876276
[TBL] [Abstract][Full Text] [Related]
32. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
33. Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone.
Lian EC; Villar MJ; Noy LI; Ruiz-Dayao Z
Am J Hematol; 2002 Apr; 69(4):294-5. PubMed ID: 11921026
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
Rosenfeld SB; Watkinson KK; Thompson BH; Macfarlane DE; Lentz SR
Thromb Haemost; 2002 May; 87(5):925-6. PubMed ID: 12038803
[No Abstract] [Full Text] [Related]
35. Disappearance of factor VIII antibodies upon frequent administration of factor VIII.
Mauser-Bunschoten EP; Roosendaal G; Bruin M; van Dijken PJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):533-7. PubMed ID: 1714856
[TBL] [Abstract][Full Text] [Related]
36. [Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus].
Pirner K; Rösler W; Kalden JR; Manger B
Z Rheumatol; 1990; 49(6):378-81. PubMed ID: 2128157
[TBL] [Abstract][Full Text] [Related]
37. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
[TBL] [Abstract][Full Text] [Related]
38. Acquired haemophilia - a study of ten cases.
Saxena R; Mishra DK; Kashyap R; Choudhry VP; Mahapatra M; Bhargava M
Haemophilia; 2000 Mar; 6(2):78-83. PubMed ID: 10781192
[TBL] [Abstract][Full Text] [Related]
39. Acquired hemophilia and its treatment.
Sultan Y
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
